Literature DB >> 18690837

Clinico-pathologic function of cerebral ABC transporters - implications for the pathogenesis of Alzheimer's disease.

Jens Pahnke1, Olaf Wolkenhauer, Markus Krohn, Lary C Walker.   

Abstract

In recent years it has become evident that ABC transporters fulfill important barrier functions in normal organs and during disease processes. Most importantly, resistance to drugs in cancer cells led to intense oncological and pharmacological investigations in which researchers were able to highlight important pharmacological interactions of chemotherapeuticals with ABC transporter function. Recently, the development of neurodegenerative diseases and the maintenance of neuronal stem cells have been linked to the activity of ABC transporters. Here, we summarize findings from cell culture experiments, animal models and studies of patients with Alzheimer's disease. Furthermore, we discuss pharmacological interactions and computational methods for risk assessment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18690837      PMCID: PMC2753594          DOI: 10.2174/156720508785132262

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  100 in total

1.  Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells.

Authors:  Y Zhang; H Han; W F Elmquist; D W Miller
Journal:  Brain Res       Date:  2000-09-08       Impact factor: 3.252

Review 2.  Functional expression and localization of P-glycoprotein at the blood brain barrier.

Authors:  Reina Bendayan; Gloria Lee; Moise Bendayan
Journal:  Microsc Res Tech       Date:  2002-06-01       Impact factor: 2.769

3.  Structure and expression of the human MDR (P-glycoprotein) gene family.

Authors:  J E Chin; R Soffir; K E Noonan; K Choi; I B Roninson
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

Review 4.  Multidrug resistance-associated proteins: expression and function in the central nervous system.

Authors:  Shannon Dallas; David S Miller; Reina Bendayan
Journal:  Pharmacol Rev       Date:  2006-06       Impact factor: 25.468

Review 5.  Wnt signaling function in Alzheimer's disease.

Authors:  G V De Ferrari; N C Inestrosa
Journal:  Brain Res Brain Res Rev       Date:  2000-08

6.  Apolipoprotein E4 promotes incipient Alzheimer pathology in the elderly.

Authors:  R W Warzok; C Kessler; G Apel; A Schwarz; R Egensperger; D Schreiber; E W Herbst; E Wolf; R Walther; L C Walker
Journal:  Alzheimer Dis Assoc Disord       Date:  1998-03       Impact factor: 2.703

7.  Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients.

Authors:  R F Ozols; R E Cunnion; R W Klecker; T C Hamilton; Y Ostchega; J E Parrillo; R C Young
Journal:  J Clin Oncol       Date:  1987-04       Impact factor: 44.544

8.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

Authors:  W J Strittmatter; K H Weisgraber; D Y Huang; L M Dong; G S Salvesen; M Pericak-Vance; D Schmechel; A M Saunders; D Goldgaber; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

9.  Subcellular localization and activity of multidrug resistance proteins.

Authors:  Asha Rajagopal; Sanford M Simon
Journal:  Mol Biol Cell       Date:  2003-04-17       Impact factor: 4.138

10.  Altered neurogenesis in Alzheimer's disease.

Authors:  Iryna Ziabreva; Elaine Perry; Robert Perry; Stephen L Minger; Antigoni Ekonomou; Stefan Przyborski; Clive Ballard
Journal:  J Psychosom Res       Date:  2006-09       Impact factor: 3.006

View more
  19 in total

Review 1.  Impaired mitochondrial energy production and ABC transporter function-A crucial interconnection in dementing proteopathies of the brain.

Authors:  Jens Pahnke; Christina Fröhlich; Markus Krohn; Toni Schumacher; Kristin Paarmann
Journal:  Mech Ageing Dev       Date:  2013-09-03       Impact factor: 5.432

2.  Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice.

Authors:  Markus Krohn; Cathleen Lange; Jacqueline Hofrichter; Katja Scheffler; Jan Stenzel; Johannes Steffen; Toni Schumacher; Thomas Brüning; Anne-Sophie Plath; Franziska Alfen; Anke Schmidt; Felix Winter; Katja Rateitschak; Andreas Wree; Jörg Gsponer; Lary C Walker; Jens Pahnke
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

Review 3.  Obstructive sleep apnea and cognitive impairment: addressing the blood-brain barrier.

Authors:  Diane C Lim; Allan I Pack
Journal:  Sleep Med Rev       Date:  2013-03-28       Impact factor: 11.609

4.  ABCB1 C3435T polymorphism influences the risk for Alzheimer's disease.

Authors:  Ágnes Fehér; Anna Juhász; Magdolna Pákáski; János Kálmán; Zoltán Janka
Journal:  J Mol Neurosci       Date:  2014-10-02       Impact factor: 3.444

5.  Reduced Alzheimer's disease pathology by St. John's Wort treatment is independent of hyperforin and facilitated by ABCC1 and microglia activation in mice.

Authors:  Jacqueline Hofrichter; Markus Krohn; Toni Schumacher; Cathleen Lange; Björn Feistel; Bernd Walbroel; Hans-Jochen Heinze; Sara Crockett; Timothy F Sharbel; Jens Pahnke
Journal:  Curr Alzheimer Res       Date:  2013-12       Impact factor: 3.498

6.  Automated detection of amyloid-β-related cortical and subcortical signal changes in a transgenic model of Alzheimer's disease using high-field MRI.

Authors:  Stefan J Teipel; Evangelia Kaza; Stefan Hadlich; Alexandra Bauer; Thomas Brüning; Anne-Sophie Plath; Markus Krohn; Katja Scheffler; Lary C Walker; Martin Lotze; Jens Pahnke
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 7.  Alzheimer's and ABC transporters--new opportunities for diagnostics and treatment.

Authors:  Jens Pahnke; Oliver Langer; Markus Krohn
Journal:  Neurobiol Dis       Date:  2014-04-16       Impact factor: 5.996

8.  Vascular and extravascular distribution of the ATP-binding cassette transporters ABCB1 and ABCC1 in aged human brain and pituitary.

Authors:  Hans-Gert Bernstein; Gloria Hölzl; Henrik Dobrowolny; Jens Hildebrandt; Kurt Trübner; Markus Krohn; Bernhard Bogerts; Jens Pahnke
Journal:  Mech Ageing Dev       Date:  2014-09-10       Impact factor: 5.432

Review 9.  Alzheimer's disease and blood-brain barrier function-Why have anti-beta-amyloid therapies failed to prevent dementia progression?

Authors:  Jens Pahnke; Lary C Walker; Katja Scheffler; Markus Krohn
Journal:  Neurosci Biobehav Rev       Date:  2009-05-27       Impact factor: 8.989

10.  Genomic background-related activation of microglia and reduced β-amyloidosis in a mouse model of Alzheimer's disease.

Authors:  Christina Fröhlich; Kristin Paarmann; Johannes Steffen; Jan Stenzel; Markus Krohn; Hans-Jochen Heinze; Jens Pahnke
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.